Nerve And Muscle Center Of Texas — Biomedical Watch V2

Essais liés8clinical trials

VilleHoustonlocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05979441

Ouvrir le site du centre

Essais cliniques associés

8

Molécule	Indication / population	Phase	NCT	Titre	Statut
Efgartigimod PH20 SC	Myopathies	Phase 3	NCT05979441	ALKIVIA+ — A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy	ENROLLING_BY_INVITATION
MT-1186	Sclérose latérale amyotrophique	Phase 3	NCT05151471	Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS	TERMINATED
Nerandomilast	Myopathies	Phase 3	NCT07789015	VERANDA™-IIM — A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies	NOT_YET_RECRUITING
VHB937	Sclérose latérale amyotrophique	Phase 2	NCT06643481	ASTRALS — A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)	ACTIVE_NOT_RECRUITING
CNP-106	Myasthénie	Phase 1/2	NCT06106672	Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis	ACTIVE_NOT_RECRUITING
Pozelimab + Cemdisiran	Myasthénie	Phase 3	NCT05070858	NIMBLE — A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis	ACTIVE_NOT_RECRUITING
Iptacopan	Myasthénie	Phase 3	NCT06517758	A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.	ACTIVE_NOT_RECRUITING
MT-1186	Sclérose latérale amyotrophique	Phase 3	NCT04569084	Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS	TERMINATED